Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rueckes

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Science (New York, N.Y.)|July 7, 2000
Carbon nanotube-based nonvolatile random access memory for molecular computingRueckes, Kim, Joselevich, et al.
Nanotechnology|January 27, 2018
NRAM: a disruptive carbon-nanotube resistance-change memoryD C Gilmer, T Rueckes, L Cleveland
BMC Pulmonary Medicine|October 5, 2014
Intestinal current measurement versus nasal potential difference measurements for diagnosis of cystic fibrosis: a case-control studyAzadeh Bagheri-Hanson, Sebastian Nedwed, Claudia Rueckes-Nilges, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 11, 2014
Nasal potential difference: Best or average result for CFTR function as diagnostic criteria for cystic fibrosis?Katherine Keenan, Julie Avolio, Claudia Rueckes-Nilges, et al.
Therapeutic Advances in Chronic Disease|August 12, 2022
Personalized medicine with drugs targeting the underlying protein defect in cystic fibrosis: is monitoring of treatment response necessary?Katharina Niedermayr, Verena Gasser, Claudia Rueckes-Nilges, et al.
American Journal of Respiratory and Critical Care Medicine|January 13, 2018
Effects of Lumacaftor-Ivacaftor Therapy on Cystic Fibrosis Transmembrane Conductance Regulator Function in Phe508del Homozygous Patients with Cystic FibrosisSimon Y Graeber, Christian Dopfer, Lutz Naehrlich, et al.
American Journal of Respiratory and Critical Care Medicine|December 22, 2021
Effects of Elexacaftor/Tezacaftor/Ivacaftor Therapy on CFTR Function in Patients with Cystic Fibrosis and One or Two <i>F508del</i> AllelesSimon Y Graeber, Constanze Vitzthum, Sophia T Pallenberg, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Science (New York, N.Y.)|July 7, 2000
Carbon nanotube-based nonvolatile random access memory for molecular computingRueckes, Kim, Joselevich, et al.
Nanotechnology|January 27, 2018
NRAM: a disruptive carbon-nanotube resistance-change memoryD C Gilmer, T Rueckes, L Cleveland
BMC Pulmonary Medicine|October 5, 2014
Intestinal current measurement versus nasal potential difference measurements for diagnosis of cystic fibrosis: a case-control studyAzadeh Bagheri-Hanson, Sebastian Nedwed, Claudia Rueckes-Nilges, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 11, 2014
Nasal potential difference: Best or average result for CFTR function as diagnostic criteria for cystic fibrosis?Katherine Keenan, Julie Avolio, Claudia Rueckes-Nilges, et al.
Therapeutic Advances in Chronic Disease|August 12, 2022
Personalized medicine with drugs targeting the underlying protein defect in cystic fibrosis: is monitoring of treatment response necessary?Katharina Niedermayr, Verena Gasser, Claudia Rueckes-Nilges, et al.
American Journal of Respiratory and Critical Care Medicine|January 13, 2018
Effects of Lumacaftor-Ivacaftor Therapy on Cystic Fibrosis Transmembrane Conductance Regulator Function in Phe508del Homozygous Patients with Cystic FibrosisSimon Y Graeber, Christian Dopfer, Lutz Naehrlich, et al.
American Journal of Respiratory and Critical Care Medicine|December 22, 2021
Effects of Elexacaftor/Tezacaftor/Ivacaftor Therapy on CFTR Function in Patients with Cystic Fibrosis and One or Two <i>F508del</i> AllelesSimon Y Graeber, Constanze Vitzthum, Sophia T Pallenberg, et al.
Pageof 1